STOCKHOLM, Feb. 5, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the fourth quarter and full year of 2025. Fourth Quarter 2025 Total revenue increased 5 per cent, 16 per cent at CER1, to SEK 7,821 M (7,436) Haematology revenue increased 25...
Hence then, the article about sobi q4 and fy 2025 report closing the year with significant growth and strategic progress was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Sobi Q4 and FY 2025 report: Closing the year with significant growth and strategic progress )
Also on site :